Ovarian Cancer Biomarkers in the COVID-19 Era
Open Access
- 29 May 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (11) , 5994
Abstract
Ovarian Cancer (OC) diagnosis is entrusted to CA125 and HE4. Since the latter has been found increased in COVID-19 patients, in this study, we aimed to evaluate the influence of SARS-CoV-2 infection on OC biomarkers. HE4 values above the cut-off were observed in 65% of OC patients and in 48% of SARS-CoV-2-positive patients (not oncologic patients), whereas CA125 values above the cut-off were observed in 71% of OC patients and in 11% of SARS-CoV-2 patients. Hence, by dividing the HE4 levels into quartiles, we can state that altered levels of HE4 in COVID-19 patients were mostly detectable in quartile I (151–300 pmol/L), while altered levels in OC patients were mostly clustered in quartile III (>600, pmol/L). In light of these observations, in order to better discriminate women with ovarian cancer versus those with COVID-19, we established a possible HE4 cut-off of 328 pmol/L by means of a ROC curve. These results demonstrate that the reliability of HE4 as a biomarker in ovarian cancer remains unchanged, despite COVID-19 interference; moreover, it is important for a proper diagnosis that whether the patient has a recent history of SARS-CoV-2 infection is determined.Keywords
Funding Information
- Sapienza Università di Roma (AR1221816B7731FA)
This publication has 49 references indexed in Scilit:
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017
- HE4 in the differential diagnosis of ovarian massesClinica Chimica Acta, 2015
- CA‐125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancersCancer, 2009
- Accuracy of CA 125 in the diagnosis of ovarian tumors: A quantitative systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cellsJournal of Experimental Medicine, 2009
- WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lungRespiratory Research, 2006
- Ovarian cancer screeningHematology/Oncology Clinics of North America, 2003
- The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoformsOncogene, 2002
- Identification by cDNA microarray of genes involved in ovarian carcinogenesis.2000
- Genetic analysis of benign, low-grade, and high-grade ovarian tumors.1995